Balaxi Pharmaceuticals Investor Relations Material
Latest events
Q4 24/25
30 May, 2025
Q3 2025
10 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Balaxi Pharmaceuticals Limited
Access all reports
Balaxi Pharmaceuticals Limited is a pharmaceutical company engaged in the manufacturing, marketing, and distribution of branded generic formulations. The company offers a wide range of dosage forms including tablets, capsules, syrups, and injectables across various therapeutic segments such as anti-infectives, gastroenterology, and pain management. The company is headquartered in Hyderabad, India, and its shares are listed on the BSE.
Key slides for Balaxi Pharmaceuticals Limited
Q3 2025
Balaxi Pharmaceuticals Limited
Q3 2025
Balaxi Pharmaceuticals Limited
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
BALAXI
Country
🇮🇳 India